X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs MYLAN (US) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   MYLAN
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
MYLAN
Dec-14
CADILA HEALTHCARE/
MYLAN
5-Yr Chart
Click to enlarge
High Rs5584,115-   
Low Rs3622,900-   
Sales per share (Unadj.) Rs116.31,408.6-  
Earnings per share (Unadj.) Rs17.9169.7-  
Cash flow per share (Unadj.) Rs23.1273.2-  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs85.4700.2-  
Shares outstanding (eoy) m1,023.74378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x4.02.5 158.8%   
Avg P/E ratio x25.720.7 124.5%  
P/CF ratio (eoy) x19.912.8 154.8%  
Price / Book Value ratio x5.45.0 107.5%  
Dividend payout %19.60-   
Avg Mkt Cap Rs m470,6641,327,031 35.5%   
No. of employees `00011.825.0 47.3%   
Total wages/salary Rs m18,5450-   
Avg. sales/employee Rs Th10,072.721,319.6 47.2%   
Avg. wages/employee Rs Th1,569.10-   
Avg. net profit/employee Rs Th1,547.72,568.3 60.3%   
INCOME DATA
Net Sales Rs m119,049532,989 22.3%  
Other income Rs m1,132-3,107 -36.4%   
Total revenues Rs m120,181529,882 22.7%   
Gross profit Rs m28,475132,557 21.5%  
Depreciation Rs m5,38839,146 13.8%   
Interest Rs m91122,990 4.0%   
Profit before tax Rs m23,30867,314 34.6%   
Minority Interest Rs m628-276 -227.4%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,6442,831 199.4%   
Profit after tax Rs m18,29264,207 28.5%  
Gross profit margin %23.924.9 96.2%  
Effective tax rate %24.24.2 575.8%   
Net profit margin %15.412.0 127.5%  
BALANCE SHEET DATA
Current assets Rs m82,005468,568 17.5%   
Current liabilities Rs m60,720366,326 16.6%   
Net working cap to sales %17.919.2 93.2%  
Current ratio x1.41.3 105.6%  
Inventory Days Days7378 93.7%  
Debtors Days Days98107 91.6%  
Net fixed assets Rs m83,703123,305 67.9%   
Share capital Rs m1,02418,848 5.4%   
"Free" reserves Rs m86,4210-   
Net worth Rs m87,445264,948 33.0%   
Long term debt Rs m25,551395,806 6.5%   
Total assets Rs m180,6531,067,186 16.9%  
Interest coverage x26.63.9 676.8%   
Debt to equity ratio x0.31.5 19.6%  
Sales to assets ratio x0.70.5 131.9%   
Return on assets %10.68.2 130.1%  
Return on equity %20.924.2 86.3%  
Return on capital %22.013.6 161.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m31,4410-   
CASH FLOW
From Operations Rs m9,19370,062 13.1%  
From Investments Rs m-9,737-55,253 17.6%  
From Financial Activity Rs m515-18,461 -2.8%  
Net Cashflow Rs m-29-3,652 0.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 69.04 Rs / USD

Compare CADILA HEALTHCARE With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: STRIDES PHARMA SCIENCE  ABBOTT INDIA  FDC LTD.  NOVARTIS  SUN PHARMA  



Today's Market

Get Ready for Record Highs(Podcast)

Globally, Traders were left scrambling after the Federal Reserve forecast zero interest-rate hikes this year and just one in 2020.

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Mar 22, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - TORRENT PHARMA COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS